Globally, we shine a spotlight on NCDs -- heart disease, diabetes, cancers and chronic lung diseases -- and advocate for their prevention. And, we want to use what we learn to establish a scalable model for prevention of chronic diseases. We then reviewed them for cultural relevancy and technical accuracy with our Behavior Change Task Force, a group of medical, health promotion and consumer communications experts. At the end of April 2010, a couple of weeks before the WHO announced a major 2011 U.N. summit on Non Communicable Diseases (NCDs), I left Merck to start Arogya World, a U.S.-based non-profit with a bold mission -- to change the course of chronic disease. In India we are implementing programs for diabetes prevention through lifestyle changes.